Flovent ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
98	Eosinophilic gastrointestinal disease	2

98. Eosinophilic gastrointestinal disease

---

Clinical trials : 172 /  Drugs : 149 - (DrugBank : 39) / Drug target genes : 38 - Drug target pathways : 135

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00426283 (ClinicalTrials.gov)	January 2007	22/1/2007	A Study of Flovent in Patients With Eosinophilic Esophagitis	A Double Blinded, Randomized Trial of Swallowed 1760mcg Fluticasone Propionate Versus Placebo in the Treatment of Eosinophilic Esophagitis	Eosinophilic Esophagitis	Drug: Flovent;Other: Placebo	Marc Rothenberg, MD	NULL	Completed	3 Years	30 Years	All	42	Phase 2	United States
2	NCT00266578 (ClinicalTrials.gov)	October 2002	15/12/2005	A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders	Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis; A Prospective, Randomized, Placebo-Controlled Trial	Eosinophilic Esophagitis	Drug: Fluticasone Propionate	Marc Rothenberg	NULL	Completed	3 Years	30 Years	Both	30	Phase 3	United States